Navigation Links
New protein found that could slow pancreatic cancer

Researchers have identified a new protein that can check the growth of pancreatic cancer//.

Pancreatic cancer develops very fast and without many symptoms from which it can be identified. The cancer often resists interventions like chemotherapy and may be diagnosed at a time when even surgery may not be able to help the patients.

Researchers from Dartmouth Medical School, US, have found a protein that inactivates the mechanism to suppress the growth of the cells. TGF-beta molecules regulate the growth of cells and stops cells from spreading quickly.

Researchers have found that a molecule called Smad7, which is found in the pancreas of some of the humans, can interfere with the functions of TGF-beta molecules by suppressing the function of the retinoblastoma proteins. The protein molecule Smad7 may also encourage the rapid growth of TGF-?ò molecules that spreads the growing cancer.

Researchers are hopeful of finding a procedure that will affect the ability of the Smad7 protein from affecting the retinoblastoma proteins. The new research also sets the pathway for developing drugs that will target on increasing the function of retinoblastoma proteins that will remain unaffected in the face of attack from the Smad7 cells and thus will help in controlling the growth process of pancreatic cancer.

Reference: Journal of Biological Chemistry, June 2005
'"/>




Page: 1

Related medicine news :

1. Special proteins to fight TB identified
2. High-protein diets may pose health risks
3. Hidden influenza virus protein found
4. Special proteins to fight TB identified
5. Importance of soy protein in your diet
6. Unfavourable Lipid-Lipoprotein profiles in older adults has been linked to abdominal visceral fat
7. Stroke victims have new hope with activated protein C
8. Mental retardation linked to brain protein
9. HIV blocking protein in Monkey
10. Obese children may have abnormalities of lipoproteins
11. Artificially made protein to inhibit angiogenesis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC ... as the official title sponsor of the Baltimore Women’s Classic, the largest all women’s ... will walk or run the course around the Baltimore Inner Harbor. Mercy has been ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Library for documenting and diagramming network and data center assets and audio-video devices ... subscribers can request new equipment shapes for free and download shapes and stencils ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  The Global ... Japanese public-private partnership formed to battle infectious diseases ... totaling US$23 million* that could help deliver a ... of debilitating conditions. This latest ... Phase 3 clinical trial testing a pediatric formulation ...
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... 29, 2017  Glenmark Pharmaceuticals, a global pharmaceutical ... an investigational fixed-dose combination of mometasone furoate (25 ... as a nasal spray being studied for the ... from a recently completed Phase 3 trial assessing ... therapy versus mometasone, olopatadine or placebo. ...
Breaking Medicine Technology: